文献速递消化系统肿瘤支持与姑息治疗

胰腺导管腺癌患者生活质量的决定因素与预后价值

Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma.
PubMed 文献 · Eur J Cancer · 2018-02-03

该研究在2478例胰腺导管腺癌患者中前瞻性评估生活质量,发现西班牙裔、分期较晚及多种社会人口学和临床因素与较低生活质量相关,且PCS和MCS低三分位均与不良预后独立相关。

要点

  • 西班牙裔患者较低PCS和MCS风险显著高于非西班牙裔白人。
  • III期和IV期患者较I期患者更易出现较低PCS。
  • PCS和MCS低三分位均与死亡风险增加独立相关。

核心结论

  • 诊断后生活质量是PDAC患者显著的预后指标,多因素决定生活质量,提示可通过干预改善生活质量和结局。

研究设计与样本

  • 基于医院的多种族/民族PDAC患者队列,前瞻性使用SF-12评估2478例患者的生活质量。

主要发现

  • 西班牙裔较非西班牙裔白人较低PCS风险OR为1.69(95%CI 1.26-2.26,P<0.001),较低MCS风险OR为1.66(95%CI 1.24-2.23,P<0.001)。
  • III期患者较低PCS风险OR为1.80(95%CI 1.10-2.94,P=0.02),IV期患者OR为2.32(95%CI 1.50-3.59,P<0.001),均以I期为参照。
  • PCS低三分位与死亡风险HR为1.94(95%CI 1.72-2.18,P<0.001),MCS低三分位HR为1.42(95%CI 1.26-1.59,P<0.001)。
  • 生活质量的其他决定因素包括性别、年龄、饮酒、吸烟、教育水平、合并症及诊断后时间。

临床怎么用

  • 临床可关注PDAC患者诊断后的生活质量,尤其对西班牙裔、晚期分期及具有其他风险因素者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quality of life (QOL) is impaired in pancreatic cancer patients. Our aim was to investigate the determinants and prognostic value of QOL after diagnosis in a hospital-based cohort of racially/ethnically diverse patients with pancreatic ductal adenocarcinoma (PDAC). PATIENTS AND METHODS: QOL was prospectively assessed using the Short Form-12 in 2478 PDAC patients. The Physical Component Summary (PCS) and Mental Component Summary (MCS) were categorised into tertiles based on their distribution. Ordered logistic regression was adopted to compare the risk of having lower PCS and MCS by patient sociodemographic and clinical characteristics. The association of PCS and MCS with mortality was assessed by Cox regression. RESULTS: Compared with non-Hispanic whites, Hispanics were at significantly higher risk of having lower PCS (odds ratio [95% CI], 1.69 [1.26-2.26]; P < 0.001) and lower MCS (1.66 [1.24-2.23]; P < 0.001). Patients diagnosed with stage III (1.80 [1.10-2.94]; P = 0.02) and stage IV (2.32 [1.50-3.59]; P < 0.001) PDAC were more likely to have lower PCS than stage I patients. Other determinants of QOL included sex, age, drinking, smoking, education level, comorbidities and time since diagnosis. The low tertile of PCS (hazard ratio [95% CI], 1.94 [1.72-2.18]; P < 0.001) and MCS (1.42 [1.26-1.59]; P < 0.001) were each related to poor prognosis. Similar results were found for non-Hispanic whites as compared with African-Americans/Hispanics/others. CONCLUSION: QOL after diagnosis is a significant prognostic indicator for patients with PDAC. Multiple factors determine QOL, suggesting possible means of intervention to improve QOL and outcomes of PDAC patients.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Deng Y, Tu H, Pierzynski JA, et al. Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer. 2018. PMID: 29413686. doi:10.1016/j.ejca.2017.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。